Novocure Ltd buy melinda
Start price
06.03.18
/
50%
€19.62
Target price
17.04.18
€21.29
Performance (%)
8.85%
End price
17.04.18
€21.35
Summary
This prediction ended on 17.04.18 with a price of €21.35. With a performance of 8.85%, the BUY prediction by melinda for Novocure Ltd closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novocure Ltd | -1.951% | -1.951% | -49.986% | -89.210% |
iShares Core DAX® | -0.612% | 0.567% | 12.585% | 14.838% |
iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% | 38.328% |
iShares Nikkei 225® | -2.647% | 0.330% | 9.482% | 5.652% |
iShares S&P 500 | -1.932% | -1.126% | 23.191% | 38.791% |
Comments by melinda for this prediction
In the thread Novocure Ltd diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 14/05 Ergebnisse Veröffentlichung
$ 21.75
+0,15 (+ 0,69%) Tumor Behandlung Fields (TTFields) - PANOVA 3 Bauchspeicheldrüsenkrebs
Phase 3 2022 2022.12.31 Phase-3-Daten im Jahr 2022 fällig.
(Zielkurs erreicht)